Find the Perfect Plan for Your Investment Journey
R
Latest price
52 Week Range
€43.98 - €60.95
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Latest price
Market Cap | €10.10B |
EV | €12.27B |
Shares Outstanding | 206.72M |
Beta | 0.54 |
Analyst Rating | HOLD |
Analyst Target Price | €57.99 |
P/E 2025E | 20.41x |
P/Revenue 2025E | 3.86x |
Revenue | 14.00% |
EPS | 2.60% |
Operating Cash Flow | 5.10% |
Free Cash Flow | 4.40% |
Revenue | 7.30% |
EPS | 13.60% |
Operating Cash Flow | 12.80% |
Free Cash Flow | 11.60% |
Gross Margin 2025E | 69.00% |
Net Profit Margin 2025E | 19.28% |
ROE 2025E | 33.53% |
ROCE 2024 | 23.38% |
DPS 2025E | €1.51 |
Payout Ratio 2025E | 62.92% |
Div. Yield 2025E | 3.08% |
DPS Last 3Y CAGR | 4.90% |
Price
%
1M
3M
6M
1Y
3Y
5Y
R
Recordati Industria Chimica e Farmaceutica S.p.A.
REC
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Koremans, Robert
Employees
4,539
Website
www.recordati.comIPO Date
1995-03-28
Headquarters
Via Matteo Civitali,1, Milan, Milan, 20148, Italy
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved